Evidence map›Paper›PMID 26061335›Full record

ArticleViruses2015

The Chikungunya Virus Capsid Protein Contains Linear B Cell Epitopes in the N- and C-Terminal Regions that are Dependent on an Intact C-Terminus for Antibody Recognition.

Lucas Y H Goh, Jody Hobson-Peters, Natalie A Prow, Kelly Baker, Thisun B H Piyasena, Carmel T Taylor, Ashok Rana, Marcus L Hastie, Jeff J Gorman, Roy A Hall

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. ArthritogenicLife (Basel, Switzerland) · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lucas Y H GohAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland 4072, Australia. l.goh1@uq.edu.au.
Jody Hobson-PetersAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland 4072, Australia. j.peters2@uq.edu.au.
Natalie A ProwAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland 4072, Australia. natalie.prow@qimrberghofer.edu.au.
Kelly BakerAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland 4072, Australia. kelly.baker1@uqconnect.edu.au.
Thisun B H PiyasenaAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland 4072, Australia. thisun.piyasena@uqconnect.edu.au.
Carmel T TaylorPublic Health Virology, Queensland Health Forensic and Scientific Services, Coopers Plain, Queensland 4108, Australia. carmel_taylor@health.qld.gov.au.
Ashok RanaProtein Discovery Centre, QIMR Berghofer Medical Research Institute, Herston, Queensland 4029, Australia. ashok.rana@qimr.edu.au.
Marcus L HastieProtein Discovery Centre, QIMR Berghofer Medical Research Institute, Herston, Queensland 4029, Australia. marcus.hastie@qimrberghofer.edu.au.
Jeff J GormanProtein Discovery Centre, QIMR Berghofer Medical Research Institute, Herston, Queensland 4029, Australia. jeffrey.gorman@qimrberghofer.edu.au.
Roy A HallAustralian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland 4072, Australia. roy.hall@uq.edu.au.
University of Queensland · AUQIMR Berghofer Medical Research Institute · AUQueensland Health · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chikungunya virus (CHIKV) is an arthropod-borne agent that causes severe arthritic disease in humans and is considered a serious health threat in areas where competent mosquito vectors are prevalent. CHIKV has recently been responsible for several millions of cases of disease, involving over 40 countries. The recent re-emergence of CHIKV and its potential threat to human health has stimulated interest in better understanding of the biology and pathogenesis of the virus, and requirement for improved treatment, prevention and control measures. In this study, we mapped the binding sites of a panel of eleven monoclonal antibodies (mAbs) previously generated towards the capsid protein (CP) of CHIKV. Using N- and C-terminally truncated recombinant forms of the CHIKV CP, two putative binding regions, between residues 1-35 and 140-210, were identified. Competitive binding also revealed that five of the CP-specific mAbs recognized a series of overlapping epitopes in the latter domain. We also identified a smaller, N-terminally truncated product of native CP that may represent an alternative translation product of the CHIKV 26S RNA and have potential functional significance during CHIKV replication. Our data also provides evidence that the C-terminus of CP is required for authentic antigenic structure of CP. This study shows that these anti-CP mAbs will be valuable research tools for further investigating the structure and function of the CHIKV CP.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, ViralCapsid ProteinsCell LineChikungunya virusEpitope MappingEpitopes, B-LymphocyteProtein BindingAntibodies, MonoclonalAntibodies, ViralCapsid ProteinsEpitopes, B-Lymphocytecapsid proteinchikungunya virusC-terminusepitope mappinglinear B cell epitopemonoclonal antibodiesN-terminus

Identifiers

PMID26061335
PMCPMC4488721
OpenAlexW2171803548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.